Ilaria Coppola

During her time at Eradigm, she have specialised in understanding the scientific and commercial value of cell & gene therapy (autologous, allogeneic), digital healthcare (digital therapeutics, screening algorithms) and rare neuroimmunological diseases. Within these fields, she have worked in CI monitoring projects, global technology landscaping and strategic workshop facilitation.